$BLUE betibeglogene autotemcel (beti-cel) One-Time Gene Therapy for β-thalassemia Continues to Demonstrate Durable Efficacy Across Pediatric and Adult Patient Populations and All Genotypes in Data Presented

on June 11, 2021 News and Tags: , , , with 0 comments
Time:
5:00 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE Long-Term Data from Pivotal KarMMa Study Continue to Demonstrate Deep and Durable Responses and Predictable Safety Profile with Bristol Myers Squibb and bluebird bio’s Abecma (idecabtagene vicleucel)

on May 19, 2021 News and Tags: , , , , , , , with 0 comments
Time:
5:00 PM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer

on May 17, 2021 News and Tags: , , , , , , , with 0 comments
Time:
7:00 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE Bristol Myers Squibb Reports First Quarter Financial Results for 2021

on April 29, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
6:59 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE bluebird bio Provides Update on Severe Genetic Disease Programs and Business Operations

on April 20, 2021 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE PsiOxus and bluebird bio Present Novel Data Combining PsiOxus T-SIGn Platform with CAR-T Therapy to Clear Primary Tumors and Metastases

on April 14, 2021 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE bluebird bio Presents Long-Term Data for elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for Cerebral Adrenoleukodystrophy (CALD)

on March 15, 2021 News and Tags: , , , with 0 comments
Time:
5:30 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE bluebird bio Provides Updated Findings from Reported Case of Acute Myeloid Leukemia (AML) in LentiGlobin for Sickle Cell Disease (SCD) Gene Therapy Program

on March 10, 2021 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE bluebird bio to Present at Cowen Health Care Conference

on February 26, 2021 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE bluebird bio Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Operational Progress

on February 23, 2021 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE bluebird bio to Present at Leerink Global Healthcare Conference

on February 22, 2021 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more

$BLUE LAWSUIT FILED: bluebird bio, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP

on February 16, 2021 News and Tags: , , , with 0 comments
Time:
9:59 AM
Symbol:
BLUE
Source:
GlobeNewswire News Releases
Read more

$BLUE bluebird bio Announces Temporary Suspension on Phase 1/2 and Phase 3 Studies of LentiGlobin Gene Therapy for Sickle Cell Disease (bb1111)

on February 16, 2021 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
BLUE
Source:
Business Wire News Releases
Read more